The approach aims to improve the etiological diagnosis of HNSCC, evaluating the prognostic value of combining HPV mRNA testing with p16 mRNA and p16 IHC, with potential implication for therapeutic decision and prognostic assessment. This evidence concerns the gene CDKN2A and head and neck squamous cell carcinoma.